Navigation Links
Atlantic Plastic Surgery Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
Date:7/31/2009

PORTSMOUTH, N.H., July 31 /PRNewswire/ -- Lawrence N. Gray, M.D., a board-certified plastic surgeon, and Mark Ballentyne, M.D. at Atlantic Plastic Surgery Center have selected Artefill, the first and only FDA-approved microsphere-enhanced collagen filler for the correction of smile lines, to treat patients who are looking for a longer lasting dermal filler. Both physicians have been avid Artefill users the past several years due to its proven success and effectiveness for the correction of wrinkles.

Dr. Lawrence Gray said, "We've had a very pleasant experience with Artefill's ease of injection and our patients are very happy with the long lasting results. Many have recommended Artefill to their friends, which is the ultimate compliment to the product. Also, happily, we have not seen any complications."

This simple, in-office procedure takes approximately fifteen minutes to complete. A patient is injected with Artefill similar to other dermal fillers with the key difference being its lasting effect. The unique microspheres in Artefill are not absorbed by the body and therefore provide the support the skin needs for long lasting natural feeling results. This is different from temporary dermal fillers that are made of different kinds of natural or synthetic materials that are completely absorbed by the body over time and require repeat injections to maintain wrinkle correction. A skin test is required prior to treatment or approximately four (4) weeks ahead of time, to ensure a patient is not allergic to the collagen or anesthetic in Artefill.

Commenting further on the product Dr. Mark Ballentyne said, "Artefill is trouble-free to administer and because the results improve over time, instead of diminishing, our patients seem to really love it. Patients are aware that they must have a skin test and then wait a month, but they are willing to do this for the long lasting results they want."

Artefill is only offered by a select group of physicians in New Hampshire and is not available at all physician offices. Drs. Gray and Ballentyne are among the company trained and select few company sponsored physicians who have the skills and experience needed to administer the product.

Jeannine a patient of Dr. Ballentyne's said, "The folds around my mouth have always been a problem for me. Since having Artefill I feel and look as if I'm in my 30's and I'm almost 58! I love the way I look in the mirror and the results have even improved over time."

About Artefill:

Artefill is the first and only FDA-approved microsphere-enhanced collagen filler for the correction of nasolabial folds, better known as smile lines. The safety and effectiveness of Artefill has been extensively studied over the past eight years. Since Artefill was approved in 2006, over 10 thousand patients have been treated successfully with very high satisfaction rates.

Suneva Medical, Inc., a medical technology company focused on developing, manufacturing and commercializing novel, differentiated aesthetic products for the dermatology, plastic and cosmetic surgery markets, markets and manufactures Artefill. The Company was formed in April 2009 to deliver the same great product that physicians and patients have embraced over the past several years. For more information visit www.artefill.com or www.sunevamedical.com.

About Atlantic Plastic Surgery Center:

Atlantic Plastic Surgery Center is the practice of New Hampshire plastic surgeon Dr. Lawrence N. Gray. He has earned a great deal of respect in both his local medical community and the national plastic surgical community through his many publications, technical skill and personal demeanor. He has a large following of satisfied patients from across New Hampshire, the United States and a number of foreign countries, who have sought him out for breast augmentation and scarless breast reduction.

Dr. Gray has received the significant honor of being only one of 15 plastic surgeons in the United States selected to offer silicone breast implants for primary augmentation. This safe, FDA approved study is a very carefully controlled process. Dr. Gray's staff is knowledgeable on the guidelines for patient participation and will carefully review them with you to determine if you qualify. For more information visit http://www.atlanticplasticsurg.com/index.html or call 1-866-264-7738.

ATTENTION MEDIA: To download Artefill patient before and after pictures visit http://www.artefill.com/content/c/beforeandafter/overview.asp.

    Contact:
    Suzanne Foley
    603-431-8819


'/>"/>
SOURCE Atlantic Plastic Surgery Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Frances Decker Named Mid-Atlantic Region Sales Executive for AllOne Health Management Solutions
2. British Council and Los Angeles Area Universities Partner to Host Transatlantic Dialogues
3. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
4. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
5. HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman & Friedman for $575 Million
6. General Atlantic and Hellman & Friedman Purchase HLTH Corporations Remaining Interest in Emdeon
7. National Atlantic Holdings Corporation to Report Fourth Quarter and Year-End 2007 Earnings on March 17, 2008
8. Atlantic Street Capital Announces First Close
9. J.D. Power and Associates Study Ranks Kaiser Permanente Highest in Member Satisfaction in South Atlantic Region
10. Z Trim Multifunctional Fiber Lightens the Menu Labeling Legislation Issue at Mid-Atlantic Food Expo, September 17 & 18
11. Advanced Wound Technologies Mid-Atlantic, Inc. Announces Name Change and Reverse Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
Breaking Medicine Technology: